BRKR - Goldman Sachs projects a rebound in life sciences tools space
2023-12-10 12:00:28 ET
More on Agilent, Danaher, etc.
- Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
- Thermo Fisher Scientific: Acquiring And Disappointing At The Same Time
- Thermo Fisher Scientific: Normalization Confirmed, In Search Of Growth Drivers
- Thermo Fisher Scientific announces pricing of offering of $2.5B of notes
- Biggest stock movers today: Agilent, Medtronic, MorphoSys, Moderna and more
For further details see:
Goldman Sachs projects a rebound in life sciences tools space